What Alacritas Consultancy Limited does

Alacrita Consultancy Limited, doing business as Alacrita Consulting or Alacrita Life Science Consulting, is a London-headquartered management consulting firm focused on the life sciences sector, with a US office in Cambridge, Massachusetts and a Delaware-incorporated subsidiary. Founded in 2009 and privately held under Alacrita Holdings Limited, the firm has operated for more than 15 years and is built around a curated expert network of 350+ specialist consultants spanning 29 functional disciplines, 22 disease areas, and 18 product modalities, supported by a core team of approximately 13 named partners/consultants and an advisory board.

The firm's service offering is organized into five practice areas: Product Development, Enterprise Development, Business Development, Investor Services, and Expert Witness Services. These serve biotech and pharmaceutical companies, venture capital and private equity investors, tech transfer offices, and animal health companies, addressing needs from R&D strategy and clinical/commercial development through transaction diligence and litigation support. The product is fundamentally senior expert judgment delivered through bespoke engagements rather than a packaged software or data product; there is no disclosed technology platform, proprietary dataset, or AI/ML capability.

Revenue is generated on a project-based consulting basis, with a network- rather than bench-heavy cost structure in which a meaningful share of engagement economics flows to the engaged specialist consultants. The firm is private and discloses no revenue, funding history, or material M&A activity. Its principal growth levers to date have been geographic (entry into the US market) and practice expansion (modalities, disease areas, and the investor and animal health segments).

Name

Alacritas Consultancy Limited

Legal name

Alacrita Consultancy Limited

Website

https://alacrita.com

Company type

Private

Founded year

2009

Operating status

Operating

Short description

Alacrita Consultancy Limited is a London-based life sciences management consulting firm with a US office, serving biotech, pharmaceutical, investor, and animal health clients via a network of 350+ specialist consultants across multiple therapeutic and functional disciplines.

Ownership category

akta.pro rank

Headquarters

HQ city

City Of London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Consulting Services: Professional consulting services delivered through project-based engagements. Services span product development, enterprise development, business development, investor services, and expert witness services. Revenue is generated through hourly consulting fees and fixed-price project engagements.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Alacrita is a biotech and pharma consulting firm that delivers strategic guidance and hands-on execution support to life science companies, investors, and academic institutions. The firm provides expert consulting across drug development, enterprise development, business development, investor services, and expert witness mandates, drawing on a network of more than 350 specialist consultants across 29 functional disciplines, 22 disease areas, and 18 product modalities.

Product overview

Alacrita is a biotech and pharma consulting firm offering strategic expertise and hands-on execution services across the life science industry. Their portfolio consists of five core service areas: Product Development (spanning opportunity mapping, preclinical strategy, clinical development, regulatory affairs, and CMC consulting), Enterprise Development (including business plans, interim CMO services, virtual biotech support, technology platform strategy, and launch planning), Business Development (due diligence, valuations, asset scouting, partnering, and academic commercialization), Investor Services (supporting fundraising and post-investment execution), and Expert Witness Services (for law firms requiring pharmaceutical expertise). The firm draws on a network of over 350 expert consultants across 29 functional disciplines, 22 disease areas, and 18 product modalities, serving biotechs, pharmaceutical companies, investors, technology transfer offices, and animal health companies. Alacrita operates offices in London (UK) and Cambridge, Massachusetts (US).

Differentiator

Problem solved

Functional benefit

Products and services

• Product Development Comprehensive consulting engagement covering drug development from opportunity mapping and preclinical strategy through clinical development, regulatory affairs, and CMC consulting. Designed for life science companies seeking specialized expertise to advance R&D programs.
• Enterprise Development
• Business Development
• Investor Services
• Expert Witness Services

Named customers4 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• ZS Associates: ZS Associates is a global consulting firm with a deep pharma and biotech practice covering sales, marketing, and R&D strategy. Larger and more technology-oriented than Alacrita but overlaps in commercial strategy and launch planning for pharma clients.
• McKinsey & Company (Pharma & Medical Products): McKinsey's Pharma & Medical Products practice serves global pharma and biotech on strategy, M&A, and organizational transformation. The dominant incumbent that competes with Alacrita especially at the larger biotech and pharma end of the market.
• L.E.K. Consulting (Life Sciences): L.E.K. Consulting's Life Sciences practice serves global pharma and biotech on strategy, M&A, and commercial excellence. A larger generalist consultancy that competes with Alacrita in pharma/biotech strategy and due diligence, particularly with mid-to-large biotechs.
• Charles River Associates (CRA Life Sciences): CRA's Life Sciences practice provides economics, strategy, and litigation consulting to pharma and biotech, including due diligence and commercial assessments. Larger, publicly-traded parent with broader service portfolio, but directly competes in life sciences strategy work.
• Huron Consulting Group (Life Sciences): Huron Consulting's Life Sciences segment advises pharma and biotech on R&D operations, regulatory, and commercial strategy. Public company with broader portfolio that overlaps Alacrita's product development and enterprise development offerings.

Direct peers

• Trinity Partners: Trinity Partners is a boutique life sciences consulting firm providing strategic and commercial advisory to biotech and pharma clients across product development, launch, and market access. Directly comparable to Alacrita in its specialist life sciences focus and project-based engagements.
• Putnam Associates: Putnam Associates is a life sciences strategy consulting firm serving biotech and pharma on commercial strategy, asset valuation, and pipeline planning. Comparable specialist positioning, similar client base, and analogous service offerings to Alacrita.
• ClearView Healthcare Partners: ClearView Healthcare Partners is a boutique consulting firm focused on pharma, biotech, and medical devices, providing strategy, commercial diligence, and market access work. Direct competitor in life sciences strategy consulting with overlapping service scope.
• Health Advances: Health Advances is a strategy consulting firm exclusively focused on life sciences, advising biotech, medtech, and pharma clients on commercial strategy, due diligence, and product development. Closely overlaps Alacrita's biotech strategy and due diligence practice.
• Defined Health: Defined Health is a boutique biopharmaceutical strategy consulting firm advising emerging and mid-cap biotechs on pipeline strategy, business development, and investor communications. Comparable niche positioning and client base to Alacrita.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks2 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/alacrita-consulting

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alacritas Consultancy Limited